About
About SynBioBeta
What — and who — is synthetic biology?
Writers
News and features
Agriculture
Health and medicine
COVID-19
Biopharma
Diagnostics
Disease prevention
Living medicines
Funding & investments
Biomanufacturing, chemicals & materials
Consumer goods
Emerging technologies
Automation and hardware
DNA data storage
DNA synthesis
Gene editing
Organism engineering
Protein engineering
Software
Space
Energy & environment
Conservation
Fuels
Entrepreneurship
Accelerators and incubators
Careers
Food and nutrition
Animal nutrition
Animal protein
Food ingredients
Non-animal protein
Policy & public
Biosecurity
DIYbio/Citizen science
Education
Events
SynBioBeta 2020
BetaSpace
Conferences
Courses
Industry tours
Working with us
Sponsors & exhibitors
Advertising
Join our team of writers
Conflict of Interest Statement
Resources
Podcast
Videos
Industry Reports
SynBioBetaLive!
Job board
Editorial guidelines
Writer resources
Newsletter
Subscribe to the SynBioBeta Digest
SynBioBeta Digest archive
Subscribe to the BetaSpace digest
BetaSpace Digest Archive
Contact
Search
About
About SynBioBeta
What — and who — is synthetic biology?
Writers
News and features
Agriculture
Health and medicine
COVID-19
Biopharma
Diagnostics
Disease prevention
Living medicines
Funding & investments
Biomanufacturing, chemicals & materials
Consumer goods
Emerging technologies
Automation and hardware
DNA data storage
DNA synthesis
Gene editing
Organism engineering
Protein engineering
Software
Space
Energy & environment
Conservation
Fuels
Entrepreneurship
Accelerators and incubators
Careers
Food and nutrition
Animal nutrition
Animal protein
Food ingredients
Non-animal protein
Policy & public
Biosecurity
DIYbio/Citizen science
Education
Events
SynBioBeta 2020
BetaSpace
Conferences
Courses
Industry tours
Working with us
Sponsors & exhibitors
Advertising
Join our team of writers
Conflict of Interest Statement
Resources
Podcast
Videos
Industry Reports
SynBioBetaLive!
Job board
Editorial guidelines
Writer resources
Newsletter
Subscribe to the SynBioBeta Digest
SynBioBeta Digest archive
Subscribe to the BetaSpace digest
BetaSpace Digest Archive
Contact
Search
Search
Author - Calvin Schmidt
Home
»
Archives for Calvin Schmidt
Why This Synthetic Biology Stock Has Doubled Since IPO
How Twist Bioscience doubled its stock price in nine months
These 37 synthetic biology companies raised $1.2B this quarter
Geltor CEO Alex Lorestani’s take on a future shaped by biodesigned products
Indistinguishable from magic? Meet Berkeley Lights
Meet the 25 synthetic biology companies that raised $652M this quarter
Why synthetic biology investors need to look beyond Silicon Valley and Boston
These 98 synthetic biology companies raised $3.8 billion in 2018
Synthetic biology investors are a mix of life sciences and traditional technology investors
Twist Bioscience Files for $86.3M IPO
Load More
About
About SynBioBeta
What — and who — is synthetic biology?
Writers
News and features
Agriculture
Health and medicine
COVID-19
Biopharma
Diagnostics
Disease prevention
Living medicines
Funding & investments
Biomanufacturing, chemicals & materials
Consumer goods
Emerging technologies
Automation and hardware
DNA data storage
DNA synthesis
Gene editing
Organism engineering
Protein engineering
Software
Space
Energy & environment
Conservation
Fuels
Entrepreneurship
Accelerators and incubators
Careers
Food and nutrition
Animal nutrition
Animal protein
Food ingredients
Non-animal protein
Policy & public
Biosecurity
DIYbio/Citizen science
Education
Events
SynBioBeta 2020
BetaSpace
Conferences
Courses
Industry tours
Working with us
Sponsors & exhibitors
Advertising
Join our team of writers
Conflict of Interest Statement
Resources
Podcast
Videos
Industry Reports
SynBioBetaLive!
Job board
Editorial guidelines
Writer resources
Newsletter
Subscribe to the SynBioBeta Digest
SynBioBeta Digest archive
Subscribe to the BetaSpace digest
BetaSpace Digest Archive
Contact
